Assessing Stoke Therapeutics: Insights From 6 Financial Analysts
Assessing Stoke Therapeutics: Insights From 6 Financial Analysts
評估Stoke Therapeutics：來自6位金融分析師的見解
Deciphering Analyst Ratings: An In-Depth...6 analysts have expressed a variety of opinions on Stoke Therapeutics (NASDAQ:STOK) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度中，有6位分析師對Stoke Therapeutics（納斯達克股票代碼：STOK）表達了不同的觀點，從看漲到看跌。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表總結了他們最近的評估，說明了過去30天不斷變化的情緒，並將其與前幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Stoke Therapeutics, presenting an average target of $20.33, a high estimate of $35.00, and a low estimate of $13.00. This upward trend is apparent, with the current average reflecting a 59.45% increase from the previous average price target of $12.75.
在評估12個月目標股價時，分析師公佈了對Stoke Therapeutics的見解，將平均目標股價定爲20.33美元，最高估計爲35.00美元，低估值爲13.00美元。這種上升趨勢顯而易見，當前的平均價格較之前的平均目標價12.75美元上漲了59.45％。
Deciphering Analyst Ratings: An In-Depth...
解密分析師評...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間